Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-50,000
Closed -$692K 4738
2024
Q1
$692K Buy
+50,000
New +$781K ﹤0.01% 3317
2018
Q1
Sell
-13,300
Closed -$907K 3697
2017
Q4
$907K Hold
13,300
﹤0.01% 2636
2017
Q3
$818K Hold
13,300
﹤0.01% 2622
2017
Q2
$836K Hold
13,300
﹤0.01% 2524
2017
Q1
$739K Hold
13,300
﹤0.01% 2507
2016
Q4
$635K Buy
13,300
+3,300
+33% +$185K ﹤0.01% 2722
2016
Q3
$648K Buy
+10,000
New +$562K ﹤0.01% 2648
2015
Q1
Sell
-132,200
Closed -$5.78M 3885
2014
Q4
$5.78M Buy
132,200
+40,000
+43% +$1.77M 0.01% 1458
2014
Q3
$4.15M Hold
92,200
0.01% 1694
2014
Q2
$6.82M Hold
92,200
0.01% 1381
2014
Q1
$7.64M Sell
92,200
-26,900
-23% -$2.36M 0.01% 1245
2013
Q4
$16.5M Buy
119,100
+35,400
+42% +$4.17M 0.02% 805
2013
Q3
$8.01M Buy
83,700
+58,300
+230% +$4.95M 0.01% 1199
2013
Q2
$1.55M Buy
+25,400
New +$1.41M ﹤0.01% 2356

Other funds holding NUS

David Shaw's NUS Position: Q2 2026 in Review

David Shaw reduced its Nu Skin (NUS) stake by 14% in Q2 2026, selling an estimated $405K and leaving 380,690 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #3206.

David Shaw first reported a position in NUS in Q2 2013 and has held it in 38 quarters since. The position peaked at $59.8M in Q2 2019. 161 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

  • David Shaw held 380,690 shares of Nu Skin worth $2.01M as of Q2 2026.
  • David Shaw sold 63,396 Nu Skin shares in Q2 2026, an estimated $405K.
  • Nu Skin made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3206 holding.
  • David Shaw first reported a position in Nu Skin in Q2 2013 and has held it in 38 quarters since.
  • David Shaw's Nu Skin position peaked at $59.8M in Q2 2019.
  • 161 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.